Skip to content

Aspen Aerogels ASPN Increase (decrease) in contract liabilities and current deferred income

Increase (decrease) in contract liabilities and current deferred income at other companies

Microvast Holdings, Inc. logo
Microvast Holdings, Inc.MVST
GHM
Graham CorporationGHM

Other financials

Income statement

See full
Revenue$37.9M-51.9%
Gross profit$4.3M-81.3%
Operating income-$20.8M+93.0%
Net income-$23.7M+92.1%
EPS (diluted)-$0.29+92.1%

Balance sheet

See full
Cash & equivalents$173.9M-9.5%
Total debt$113.4M-18.8%
Total equity$213.5M-32.2%
Total assets$410.5M-26.0%

Cash flow

See full
Operating cash flow$34.1M+506%
CapEx$1.4M-89.5%
Free cash flow$32.8M+545%

Valuation

See full
Market cap$470.74M-1.1%
Enterprise value$410.28M-3.1%
P/S+1.0×

Profitability

See full
Gross margin32.9%-7.1pp
Operating margin-43.3%-8.2pp
Net margin-48.6%-9.9pp
FCF margin-22.3%-10.1pp

Returns & leverage

See full
Return on equity-42.4%-12.2pp
Debt / equity0.5×+0.1×
Current ratio2.9×-1.3×

Where this comes from

Reported directly by Aspen Aerogels in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: Aspen Aerogels’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aspen Aerogels's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aspen Aerogels's increase (decrease) in contract liabilities and current deferred income?
Aspen Aerogels (ASPN) reported increase (decrease) in contract liabilities and current deferred income of $35.32M in Q1 2026.
How has Aspen Aerogels's increase (decrease) in contract liabilities and current deferred income changed year-over-year?
Aspen Aerogels's increase (decrease) in contract liabilities and current deferred income increased by 7819.1% year-over-year, from $446K to $35.32M.